Sonic Healthcare Limited
Sonic Healthcare Limited SHL.AX Peers
See (SHL.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SHL.AX | $26.27 | -2.16% | 12.62B | 23.04 | $1.14 | +4.07% |
| IDX.AX | $2.42 | -1.63% | 900.76M | 121.00 | $0.02 | +2.40% |
| HLS.AX | $1.00 | -4.33% | 722.50M | -1.04 | -$0.96 | +41.51% |
| ACL.AX | $2.97 | -3.57% | 582.90M | 19.80 | $0.15 | +4.21% |
| MVF.AX | $0.79 | +1.95% | 305.86M | -78.50 | -$0.01 | +6.50% |
| GSS.AX | $0.58 | +0.88% | 130.60M | -5.75 | -$0.10 | N/A |
| MAP.AX | $0.15 | N/A | 67.18M | -5.00 | -$0.03 | N/A |
| PEB.AX | $0.07 | -6.67% | 56.83M | -1.75 | -$0.04 | N/A |
| IIQ.AX | $0.40 | +8.11% | 44.65M | -5.71 | -$0.07 | N/A |
| CTE.AX | $0.76 | N/A | 37.10M | 19.00 | $0.04 | +2.63% |
Stock Comparison
SHL.AX vs IDX.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, IDX.AX has a market cap of 900.76M. Regarding current trading prices, SHL.AX is priced at $26.27, while IDX.AX trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas IDX.AX's P/E ratio is 121.00. In terms of profitability, SHL.AX's ROE is +0.07%, compared to IDX.AX's ROE of +0.01%. Regarding short-term risk, SHL.AX is more volatile compared to IDX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs HLS.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, HLS.AX has a market cap of 722.50M. Regarding current trading prices, SHL.AX is priced at $26.27, while HLS.AX trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas HLS.AX's P/E ratio is -1.04. In terms of profitability, SHL.AX's ROE is +0.07%, compared to HLS.AX's ROE of -0.02%. Regarding short-term risk, SHL.AX is less volatile compared to HLS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs ACL.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, ACL.AX has a market cap of 582.90M. Regarding current trading prices, SHL.AX is priced at $26.27, while ACL.AX trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas ACL.AX's P/E ratio is 19.80. In terms of profitability, SHL.AX's ROE is +0.07%, compared to ACL.AX's ROE of +0.18%. Regarding short-term risk, SHL.AX is less volatile compared to ACL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs MVF.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, MVF.AX has a market cap of 305.86M. Regarding current trading prices, SHL.AX is priced at $26.27, while MVF.AX trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas MVF.AX's P/E ratio is -78.50. In terms of profitability, SHL.AX's ROE is +0.07%, compared to MVF.AX's ROE of -0.01%. Regarding short-term risk, SHL.AX is less volatile compared to MVF.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs GSS.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, GSS.AX has a market cap of 130.60M. Regarding current trading prices, SHL.AX is priced at $26.27, while GSS.AX trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas GSS.AX's P/E ratio is -5.75. In terms of profitability, SHL.AX's ROE is +0.07%, compared to GSS.AX's ROE of -0.39%. Regarding short-term risk, SHL.AX is more volatile compared to GSS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs MAP.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, MAP.AX has a market cap of 67.18M. Regarding current trading prices, SHL.AX is priced at $26.27, while MAP.AX trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas MAP.AX's P/E ratio is -5.00. In terms of profitability, SHL.AX's ROE is +0.07%, compared to MAP.AX's ROE of -0.48%. Regarding short-term risk, SHL.AX is less volatile compared to MAP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs PEB.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, PEB.AX has a market cap of 56.83M. Regarding current trading prices, SHL.AX is priced at $26.27, while PEB.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas PEB.AX's P/E ratio is -1.75. In terms of profitability, SHL.AX's ROE is +0.07%, compared to PEB.AX's ROE of -0.57%. Regarding short-term risk, SHL.AX is less volatile compared to PEB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs IIQ.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, IIQ.AX has a market cap of 44.65M. Regarding current trading prices, SHL.AX is priced at $26.27, while IIQ.AX trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas IIQ.AX's P/E ratio is -5.71. In terms of profitability, SHL.AX's ROE is +0.07%, compared to IIQ.AX's ROE of -0.36%. Regarding short-term risk, SHL.AX is less volatile compared to IIQ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs CTE.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, CTE.AX has a market cap of 37.10M. Regarding current trading prices, SHL.AX is priced at $26.27, while CTE.AX trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas CTE.AX's P/E ratio is 19.00. In terms of profitability, SHL.AX's ROE is +0.07%, compared to CTE.AX's ROE of +1.33%. Regarding short-term risk, SHL.AX is less volatile compared to CTE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs BDX.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, BDX.AX has a market cap of 27.81M. Regarding current trading prices, SHL.AX is priced at $26.27, while BDX.AX trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas BDX.AX's P/E ratio is -2.53. In terms of profitability, SHL.AX's ROE is +0.07%, compared to BDX.AX's ROE of -0.90%. Regarding short-term risk, SHL.AX is less volatile compared to BDX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs LDX.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, LDX.AX has a market cap of 19.46M. Regarding current trading prices, SHL.AX is priced at $26.27, while LDX.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas LDX.AX's P/E ratio is -2.60. In terms of profitability, SHL.AX's ROE is +0.07%, compared to LDX.AX's ROE of -0.59%. Regarding short-term risk, SHL.AX is less volatile compared to LDX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs RHY.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, RHY.AX has a market cap of 17.68M. Regarding current trading prices, SHL.AX is priced at $26.27, while RHY.AX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas RHY.AX's P/E ratio is -6.10. In terms of profitability, SHL.AX's ROE is +0.07%, compared to RHY.AX's ROE of -0.76%. Regarding short-term risk, SHL.AX is more volatile compared to RHY.AX. This indicates potentially higher risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs GTG.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, GTG.AX has a market cap of 9.45M. Regarding current trading prices, SHL.AX is priced at $26.27, while GTG.AX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas GTG.AX's P/E ratio is -3.90. In terms of profitability, SHL.AX's ROE is +0.07%, compared to GTG.AX's ROE of -3.62%. Regarding short-term risk, SHL.AX is more volatile compared to GTG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs IBX.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, IBX.AX has a market cap of 2.62M. Regarding current trading prices, SHL.AX is priced at $26.27, while IBX.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas IBX.AX's P/E ratio is -0.26. In terms of profitability, SHL.AX's ROE is +0.07%, compared to IBX.AX's ROE of +0.55%. Regarding short-term risk, SHL.AX is less volatile compared to IBX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for SHL.AX.
SHL.AX vs WFL.AX Comparison
SHL.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHL.AX stands at 12.62B. In comparison, WFL.AX has a market cap of 1.48M. Regarding current trading prices, SHL.AX is priced at $26.27, while WFL.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHL.AX currently has a P/E ratio of 23.04, whereas WFL.AX's P/E ratio is -0.10. In terms of profitability, SHL.AX's ROE is +0.07%, compared to WFL.AX's ROE of +11.65%. Regarding short-term risk, SHL.AX is more volatile compared to WFL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for SHL.AX.